Health insurers process more than five billion payment claims annually, federal figures show. About 850 million are denied, ...
Background: Previous studies have identified significant variability in attention-deficit/hyperactivity disorder (ADHD) prevalence estimates worldwide, largely ...
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the treatment of attention-deficit ...